secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001040130-25-000086
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express warns Q2 net sales down ~25% YoY; receives Nasdaq delisting notice
--------------------------------------------------------------------------------

- Preliminary Q2 net sales estimated at $43.4M-$44.5M vs $58.0M (restated) prior year.
- Six-month net sales estimated at $94.5M-$95.6M vs $124.3M (restated) prior year.
- Cannot estimate operating income due to pending goodwill impairment analysis.
- Cash $36.1M, no debt as of September 30, 2025.
- Nasdaq non-compliance for late Q1 and Q2 10-Qs; compliance plan update due by Nov 28, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000086/0001040130-25-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000086/pets-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001040130-25-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer